Although in recent decades we have observed a decrease in the probability, which is probably linked to the early patency of diseased blood vessels and the widespread use of related drugs, such as β-blockers, ACEI/ARB, and aldosterone receptor antagonists [26], the disease burden caused by acute coronary syndrome with atrial fibrillation cannot be ignored. This evidence concerns the gene NR3C2 and acute coronary syndrome.